Disclosure Panels Details Page
Chronic Myeloid Leukemia Panel - Disclosures as of 01/28/2022
| Panel Member | Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty for Panel Member or Dependent | Spouse/Domestic Partner/Dependent Potential Conflict | Date Completed |
|---|---|---|---|---|---|---|
| Jessica Altman MD | AbbVie, Inc. ALX Oncology Amgen Inc. Aprea Aptos Astellas Pharma US, Inc. BioSight Bristol-Myers Squibb Company Cellectis Fujifilm Corporation Gilead Sciences, Inc. GlycoMimetics, Inc. ImmunoGen, Inc. Kartos Kura Oncology, Inc. MEI Pharma Inc. Rafael |
AbbVie, Inc. Astellas Pharma US, Inc. BlueBird Bio Kura Oncology, Inc. Syros Pharmaceuticals |
GlycoMimetics, Inc. | None | NA | 10/12/2021 |
| Maria Amaya MD,PhD | None | None | None | None | NA | 04/29/2021 |
| Ellin Berman MD | Novartis Pharmaceuticals Corporation Takeda Pharmaceuticals North America, Inc. |
Novartis Pharmaceuticals Corporation | None | None | NA | 12/14/2021 |
| Ravi Bhatia MD | None | None | None | None | NA | 12/12/2021 |
| Marian Birkeland PhD | None | None | None | None | NA | 10/22/2021 |
| Robert Collins MD | None | Ro5 Inc. | None | None | NA | 07/23/2021 |
| Peter Curtin MD | CRISPR Therapeutics | None | None | None | NA | 03/04/2021 |
| Daniel DeAngelo MD,PhD | AbbVie, Inc. Blueprint Medicines Daiichi- Sankyo Co. GlycoMimetics, Inc. Mt Sinai MPN Consortium |
None | Amgen Inc. Blueprint Medicines Jazz Pharmaceuticals Inc. Kite Pharma Novartis Pharmaceuticals Corporation Pfizer Inc. Servier Takeda Pharmaceuticals North America, Inc. |
None | NA | 01/26/2022 |
| Sarah DeVincenzo PharmD,BCPS | None | None | None | None | NA | 11/09/2021 |
| Tanya Fischer MLIS,MEd | None | None | None | None | NA | 10/07/2021 |
| Jason Gotlib MD,MS | AbbVie, Inc. Blueprint Medicines Bristol-Myers Squibb Company Celgene Corporation Deciphera Pharmaceuticals, Inc. Incyte Corporation Kartos PharmaEssentia Promedior, Inc. Protagonist Therapeutics |
AbbVie, Inc. Blueprint Medicines PharmaEssentia Protagonist Therapeutics |
None | None | NA | 04/26/2021 |
| Kristina Gregory MSN,RN,OCN | None | None | None | None | NA | 11/11/2021 |
| Evelyn Handel PharmD,BCPS,BCOP | None | None | None | None | NA | 01/26/2022 |
| Gabriela Hobbs MD | None | AbbVie, Inc. Blueprint Medicines Bristol-Myers Squibb Company Celgene Corporation Constellation Incyte Corporation Novartis Pharmaceuticals Corporation Takeda Pharmaceuticals North America, Inc. |
None | None | NA | 10/19/2021 |
| Hagop Kantarjian MD | None | None | Bristol-Myers Squibb Company Novartis Pharmaceuticals Corporation Pfizer Inc. Takeda Pharmaceuticals North America, Inc. |
None | NA | 01/21/2022 |
| Lori Maness MD | None | None | None | None | NA | 12/02/2021 |
| Monica Mead MD | None | None | None | None | NA | 11/12/2020 |
| Leland Metheny MD | Adienne Pfizer Inc. |
Gamida Incyte Corporation Taiho Parmaceuticals Co., Ltd. |
None | None | NA | 09/09/2021 |
| Sanjay Mohan MD,MSCI | Incyte Corporation Karyopharm Therapeutics Taiho Parmaceuticals Co., Ltd. |
None | None | None | NA | 01/28/2022 |
| Joseph Moore MD | Pharmacyclics | None | None | None | NA | 01/21/2022 |
| Vivian Oehler MD | Actuate/Courante Oncology Ascentage Astex Pharmaceuticals Blueprint Medicines Bristol-Myers Squibb Company Cepheid Novartis Pharmaceuticals Corporation Pfizer Inc. |
None | ASCO Advantage OncLive |
None | NA | 10/01/2021 |
| Mrinal Patnaik MD | Kura Oncology, Inc. | None | None | None | NA | 12/23/2021 |
| Donna Powell DHSc,CMD,RT(T) | None | None | None | None | NA | 11/29/2021 |
| Keith Pratz MD | AbbVie, Inc. Agios, Inc. Astellas Pharma US, Inc. Takeda Pharmaceuticals North America, Inc. |
AbbVie, Inc. Astellas Pharma US, Inc. Bristol-Myers Squibb Company |
None | None | NA | 03/04/2021 |
| Iskra Pusic MD,MSCI | GlaxoSmithKline Kadmon Pharmacyclics |
None | None | None | NA | 10/11/2021 |
| Michal Rose MD | None | None | None | None | NA | 01/05/2021 |
| Neil Shah MD,PhD | Aerovate Therapeutics Bristol-Myers Squibb Company PTC Therapeutics Sierra Oncology Taiho Parmaceuticals Co., Ltd. |
Aerovate Therapeutics | None | None | NA | 12/07/2021 |
| B. Douglas Smith MD | Celgene Corporation Cellularity |
Agios, Inc. Jubilant Novartis Pharmaceuticals Corporation Pfizer Inc. |
None | None | NA | 10/11/2021 |
| Hema Sundar PhD | None | None | None | Progenra | NA | 11/30/2021 |
| Bettyanne Sunderland BSN,RN,OCN,ONN-CG | None | None | None | None | NA | 10/18/2021 |
| Kendra Sweet MD,MS | AROG Immunogen Incyte Corporation |
AROG Pharmaceuticals Bristol-Myers Squibb Company Novartis Pharmaceuticals Corporation |
Astellas Pharma US, Inc. Curio Science |
None | NA | 03/05/2021 |
| Moshe Talpaz MD | Theravance | Bristol-Myers Squibb Company Novartis Pharmaceuticals Corporation |
None | None | NA | 01/20/2022 |
| Tiffany Tanaka MD | None | None | CTI BioPharma Corp. | None | NA | 01/24/2022 |
| James Thompson MD,MS | Bristol-Myers Squibb Company Novartis Pharmaceuticals Corporation |
None | None | None | NA | 11/05/2021 |
| Jennifer Vaughn MD,MSPH | None | None | None | None | NA | 03/09/2021 |
| Jeanna Welborn MD | None | None | None | None | NA | 12/13/2021 |
| David Yang MD | Flambeau Diagnostics | None | None | None | NA | 12/07/2021 |